Minerva Neurosciences is a Burlington, Massachusetts drug developer working on roluperidone, a candidate for schizophrenia. It last closed at $2.00 on Nov 20, down 5.66% on the day. The next earnings report for NERV is expected around Wed, Mar 10, 2027. For the quarter ended Sep 2026, NERV reported EPS of -$0.19. Over its last 4 reports the stock moved an average of 4.6% the session after earnings.
AI Auto Pilots
Is NERV in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold NERV.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on NERVStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
NERV · as of the Nov 20 close · updated each morning
Downtrend, nearing oversold
The stock is 16% below its 20 day and 40% below its 50 day average. It is 138% below its 200 day average, so the longer trend is down. Momentum is fading (RSI 33), near oversold. The nearest support is the 52 week low at $1.96, and the nearest resistance the Pivot at $2.04.
Short trendBearish
Long trendBearish
MomentumFading
StretchNear oversold
VolatilityHigh, 11.8%/day
Key levels
$8.8052 week high+340.0%
$4.75200 day average+137.5%
$3.63100 day average+81.5%
$2.8050 day average+40.0%
$2.65Swing high (Oct 23)+32.5%
$2.3120 day average+15.5%
$2.09Pivot R1+4.5%
$2.04Pivot+2.0%
$2.00Last close
$1.9652 week low−2.0%
$1.96Swing low (Oct 30)−2.0%
$1.95Pivot S1−2.5%
Indicators
RSI (14)
33.07
Weak, oversold below 30
Neutral
MACD
-0.18
Below its signal line
Bearish
Stochastic
13.3
Near the bottom of its range
Oversold
ADX (14)
20.2
Weak trend
Williams %R
-98.7
Oversold below −80, overbought above −20
Oversold
CCI (20)
-153.2
Oversold below −100, overbought above 100
Oversold
Rate of change
−17.4%
Change over 10 sessions
Bearish
ATR (14)
$0.24
Typical daily range, 11.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityNormal, 33.9%/day
Key levels
$8.8052 week high+340.0%
$4.75200 day average+137.5%
$3.63100 day average+81.5%
$2.8050 day average+40.0%
$2.65Swing high (Oct 23)+32.5%
$2.3120 day average+15.5%
$2.09Pivot R1+4.5%
$2.04Pivot+2.0%
$2.00Last close
$1.9652 week low−2.0%
$1.96Swing low (Oct 30)−2.0%
$1.95Pivot S1−2.5%
Indicators
RSI (14)
27.75
Oversold below 30
Oversold
MACD
-0.71
Below its signal line
Bearish
Stochastic
7.6
Near the bottom of its range
Oversold
ADX (14)
18.4
No clear trend
Williams %R
-98.9
Oversold below −80, overbought above −20
Oversold
CCI (20)
-122.2
Oversold below −100, overbought above 100
Oversold
Rate of change
−51.8%
Change over 10 sessions
Bearish
ATR (14)
$0.68
Typical daily range, 33.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for NERV
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how NERV did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow NERV usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for NERVHow many large options trades hit NERV, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in NERV in the last 90 days.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether NERV is in one of them and how their past NERV trades turned out.
Minerva Neurosciences is a pharmaceutical company based in Burlington, Massachusetts. Its main focus is roluperidone, a drug candidate being developed to treat negative symptoms of schizophrenia. The candidate is still moving through clinical trials and the U.S. regulatory approval process, so it is not yet approved for sale. The company's intended customers are patients with schizophrenia, along with the doctors and healthcare providers who treat them.